NDC 50881-026 – Pemazyre
Pemigatinib 4.5 mg/1 · Tablet · Oral
Product NDC50881-026
Product details
- Brand name
- Pemazyre
- Generic name
- Pemigatinib
- Labeler
- Incyte Corporation
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA213736
- Marketed since
- April 17, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Pemigatinib 4.5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50881-026-01 | 14 TABLET in 1 BOTTLE, PLASTIC (50881-026-01) | Apr 17, 2020 |